These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32614793)

  • 1. "Stopping the itch": mass drug administration for scabies outbreak control covered for over nine million people in Ethiopia.
    Enbiale W; Baynie TB; Ayalew A; Gebrehiwot T; Getanew T; Ayal A; Ayalew M; De Vries HJ; Takarinda K; Manzi M; Zachriah R
    J Infect Dev Ctries; 2020 Jun; 14(6.1):28S-35S. PubMed ID: 32614793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does mass drug administration for community-based scabies control works? The experience in Ethiopia.
    Enbiale W; Ayalew A; Gebrehiwot T; Mulu Y; Azage M; Zachariah R; Romani L; Verdonck K; Van Griensven J; De Vries HJ
    J Infect Dev Ctries; 2020 Jun; 14(6.1):78S-85S. PubMed ID: 32614801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ignoring the "Itch": The Global Health Problem of Scabies.
    Stamm LV; Strowd LC
    Am J Trop Med Hyg; 2017 Dec; 97(6):1647-1649. PubMed ID: 29016295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ivermectin mass drug administration for onchocerciasis elimination: can it reduce the prevalence of scabies in Ethiopia?
    Amsalu T; Enbiale W; Manaye N; Ayalew A; Workineh A; De Vries H; Van Griensven J
    J Infect Dev Ctries; 2022 Aug; 16(8.1):35S-40S. PubMed ID: 36156500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for a cluster-randomised non-inferiority trial of one versus two doses of ivermectin for the control of scabies using a mass drug administration strategy (the RISE study).
    Lake SJ; Phelan SL; Engelman D; Sokana O; Nasi T; Boara D; Gorae C; Schuster T; Grobler AC; Osti MH; Andrews R; Marks M; Whitfeld MJ; Romani L; Kaldor J; Steer A
    BMJ Open; 2020 Aug; 10(8):e037305. PubMed ID: 32868360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No secondary impact of ivermectin mass drug administration for onchocerciasis elimination on the prevalence of scabies in northwestern Ethiopia.
    Yirgu R; Middleton J; Fekadu A; Davey G; Bremner S; Jones CI; Cassell JA
    Trans R Soc Trop Med Hyg; 2024 Feb; 118(2):110-117. PubMed ID: 37665766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial.
    Romani L; Marks M; Sokana O; Nasi T; Kamoriki B; Cordell B; Wand H; Whitfeld MJ; Engelman D; Solomon AW; Kaldor JM; Steer AC
    Lancet Infect Dis; 2019 May; 19(5):510-518. PubMed ID: 30956111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs of mass drug administration for scabies in Fiji.
    Mow M; Thean LJ; Parnaby M; Mani J; Rafai E; Sahukhan A; Kama M; Tuicakau M; Kado J; Romani L; Engelman D; Whitfeld M; Kaldor J; Steer A; Carvalho N
    PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010147. PubMed ID: 35113888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coverage, social mobilization and challenges of mass Zithromax administration campaign in South and South East zones of Tigray, Northern Ethiopia: A cross sectional study.
    Mulugeta A; Gebregergs GB; Asfaw S; Yemane D; Mitiku M; Meresa B; Gigar G; Kidane A
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006288. PubMed ID: 29481558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation and evaluation of an algorithm for the management of scabies outbreaks.
    Mueller SM; Gysin S; Schweitzer M; Schwegler S; Haeusermann P; Itin P; Bart T; Denz RS; Steffen T; Kuehl R; Widmer AF; Brandt O
    BMC Infect Dis; 2019 Feb; 19(1):200. PubMed ID: 30819115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A framework for scabies control.
    Engelman D; Marks M; Steer AC; Beshah A; Biswas G; Chosidow O; Coffeng LE; Lardizabal Dofitas B; Enbiale W; Fallah M; Gasimov E; Hopkins A; Jacobson J; Kaldor JM; Ly F; Mackenzie CD; McVernon J; Parnaby M; Rainima-Qaniuci M; Sokana O; Sankara D; Yotsu R; Yajima A; Cantey PT
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009661. PubMed ID: 34473725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community control strategies for scabies: A cluster randomised noninferiority trial.
    Hardy M; Samuela J; Kama M; Tuicakau M; Romani L; Whitfeld MJ; King CL; Weil GJ; Schuster T; Grobler AC; Engelman D; Robinson LJ; Kaldor JM; Steer AC
    PLoS Med; 2021 Nov; 18(11):e1003849. PubMed ID: 34758017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute morbidity associated with scabies and other ectoparasitoses rapidly improves after treatment with ivermectin.
    Worth C; Heukelbach J; Fengler G; Walter B; Liesenfeld O; Hengge U; Feldmeier H
    Pediatr Dermatol; 2012; 29(4):430-6. PubMed ID: 22211573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of scabies in a tribal community using mass screening and treatment with oral ivermectin -A cluster randomized controlled trial in Gadchiroli, India.
    Behera P; Munshi H; Kalkonde Y; Deshmukh M; Bang A
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009330. PubMed ID: 33861741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scabies prevalence after ivermectin-based mass drug administration for lymphatic filariasis, Samoa 2018-2019.
    Willis GA; Kearns T; Mayfield HJ; Sheridan S; Thomsen R; Naseri T; David MC; Engelman D; Steer AC; Graves PM; Lau CL
    PLoS Negl Trop Dis; 2023 Aug; 17(8):e0011549. PubMed ID: 37607196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, Diagnosis, and Treatment of Scabies in a Dermatology Office.
    Anderson KL; Strowd LC
    J Am Board Fam Med; 2017 Jan; 30(1):78-84. PubMed ID: 28062820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized Trial of Community Treatment With Azithromycin and Ivermectin Mass Drug Administration for Control of Scabies and Impetigo.
    Marks M; Toloka H; Baker C; Kositz C; Asugeni J; Puiahi E; Asugeni R; Azzopardi K; Diau J; Kaldor JM; Romani L; Redman-MacLaren M; MacLaren D; Solomon AW; Mabey DCW; Steer AC
    Clin Infect Dis; 2019 Mar; 68(6):927-933. PubMed ID: 29985978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of ivermectin administered for scabies treatment on the prevalence of head lice in Atoifi, Solomon Islands.
    Coscione S; Esau T; Kekeubata E; Diau J; Asugeni R; MacLaren D; Steer AC; Kositz C; Marks M
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006825. PubMed ID: 30252856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scabies community prevalence and mass drug administration in two Fijian villages.
    Haar K; Romani L; Filimone R; Kishore K; Tuicakau M; Koroivueta J; Kaldor JM; Wand H; Steer A; Whitfeld M
    Int J Dermatol; 2014 Jun; 53(6):739-45. PubMed ID: 24168177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Undiagnosed Index Case Leading to a Nosocomial Scabies Outbreak: How Mass Single-Dose Ivermectin Treatment Can Help Control a Nosocomial Epidemic.
    Boyer PH; Deboscker S; Hernandez C; Ramsheyi M; Schneider P; Foeglé J; Lavigne T
    Infect Control Hosp Epidemiol; 2018 May; 39(5):631-632. PubMed ID: 29457578
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.